Istituto Clinico Humanitas

Rozzano (milano) 20089

0 studies enrolling now · 3 studies all time

What they study most

Acute Coronary Syndrome, Coronary Artery Disease, Lymphoma, Myocardial Infarction, Non-Hodgkin's Disease, Percutaneous Coronary Intervention

Studies at this site

• An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas — Completed
• A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) — Completed
• Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) — Stopped early